Cargando…
Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
Background: Vancomycin is widely used for empirical antimicrobial therapy in critically ill patients with sepsis. Continuous infusion (CI) may provide more stable exposure than intermittent infusion, but optimal dosing remains challenging. The aims of this study were to perform population pharmacoki...
Autores principales: | Garreau, Romain, Falquet, Benoît, Mioux, Lisa, Bourguignon, Laurent, Ferry, Tristan, Tod, Michel, Wallet, Florent, Friggeri, Arnaud, Richard, Jean-Christophe, Goutelle, Sylvain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532763/ https://www.ncbi.nlm.nih.gov/pubmed/34680809 http://dx.doi.org/10.3390/antibiotics10101228 |
Ejemplares similares
-
Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm
por: Pham, Truong-Thanh, et al.
Publicado: (2022) -
Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection
por: Goutelle, Sylvain, et al.
Publicado: (2021) -
Quantitative Prediction of Drug–Drug Interactions Involving Inhibitory Metabolites by Physiologically Based Pharmacokinetic Models: Is it Worth It?
por: Tod, M, et al.
Publicado: (2017) -
Replicating finding, answering questions: closer to the truth about COVID-19 associated VAP
por: Vacheron, Charles-Hervé, et al.
Publicado: (2023) -
Azithromycin for COVID-19: More Than Just an Antimicrobial?
por: Bleyzac, Nathalie, et al.
Publicado: (2020)